The life sciences industry is well positioned for growth in 2025, fueled by strong investor interest and technological advancements, especially in AI. Life sciences venture capital (VC) funding and ...

Solomon Shibairo is the current Vice Chancellor (VC) of Masinde Muliro University of Science and Technology (MMUST), ...

In its 53-year history, Sofinnova Partners has invested in more than 500 companies. The venture capital firm now has €1.2 billion to invest in more. The additional funds have come at a fast clip.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Emerging markets are making ...

Since the previous quarter’s Life Sciences Snapshot, robust dealmaking activity in Q3 has launched YTD life sciences VC deal activity to near parity with 2023 figures, firmly positioning 2024 as the ...

Australian life sciences venture capital firm Brandon Capital has closed its largest fund yet, raising A$439 million (about $290 million) for the sixth Brandon BioCatalyst Fund. The heaps of cash will ...

Two affiliates of Apple Tree Partners have filed for bankruptcy, a move designed to continue funding the venture firm's portfolio biotechs as a funding dispute with a top investor plays out. Yesterday ...

Challenges in the Denver-Boulder life sciences real estate market have leveled off with a spike in leasing activity and venture capital funding to local companies at the end of 2024. The metro area’s ...